Search Results

Absence of transmission of vYF next generation Yellow Fever vaccine in mosquitoes.

by Rachel Bellone, Laurence Mousson, Chloé Bohers, Nathalie Mantel, Anna-Bella Failloux
Published in PLOS Neglected Tropical Diseases (2022)

The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.

by Maíra Aguiar, Nico Stollenwerk, Scott B Halstead
Published in PLOS Neglected Tropical Diseases (2016)

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response.

by Jacky Flipse, Jolanda M Smit
Published in PLOS Neglected Tropical Diseases (2015)

Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series.

by Francesco Checchi, Patrice Piola, Harriet Ayikoru, Florence Thomas, Dominique Legros, Gerardo Priotto
Published in PLoS Neglected Tropical Diseases (2007)

Projected Impact of Dengue Vaccination in Yucatán, Mexico.

by Thomas J Hladish, Carl A B Pearson, Dennis L Chao, Diana Patricia Rojas, Gabriel L Recchia, Héctor Gómez-Dantés, M Elizabeth Halloran, Juliet R C Pulliam, Ira M Longini
Published in PLOS Neglected Tropical Diseases (2016)

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015.

by Pedro L Moro, Emily Jane Woo, Wendy Paul, Paige Lewis, Brett W Petersen, Maria Cano
Published in PLOS Neglected Tropical Diseases (2016)

Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement.

by Chen-Yi Chiang, Chien-Hsiung Pan, Chun-Hsiang Hsieh, Jy-Ping Tsai, Mei-Yu Chen, Hsueh-Hung Liu, Shih-Jen Liu, Pele Chong, Chih-Hsiang Leng, Hsin-Wei Chen
Published in PLoS Neglected Tropical Diseases (2013)